Plexxikon is a developer of small-molecule pharmaceuticals, including products for a wide variety of therapeutic areas. Plexxikon's drugs – such as Zelboraf – are used to treat cardio-renal, neurological, inflammation, metabolic conditions and oncology. Plexxikon is a division of the Daiichi Sankyo Group.